Amplify Weight Loss Drug & Treatment ETF
$25.95+$0.59 (+2.35%)
Amplify Weight Loss Drug & Treatment ETF’s quoted price sits in the upper half of its reported 52-week range, 7.12% below the high.
AMEX · ION · USD
Stock price, dividends
Quote as of Oct 30, 2026, 06:40 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
ProShares S&P Global Core Battery Metals ETF’s quoted price sits in the lower half of its reported 52-week range, 46.07% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
ProShares S&P Global Core Battery Metals ETF’s forward annual dividend is $1.11 per share, paid quarterly. The forward yield is 2.97% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
ION is a passively managed ETF that provides exposure to companies engaged in the mining of metals used in battery production. The portfolio is comprised of stocks and depositary receipts that had positive total revenue and production value (dollar market value) from the mining of lithium, nickel, and cobalt during the prior year. Companies could be of any market capitalization from both developed and emerging countries. Using a mathematical approach, the fund determines the type, quantity, and mix of investment positions that are expected to produce returns. Weighting is set to each securitys ranking based on production-value-to-revenue ratio divided by the sum of all ranks. A basket liquidity maximum weight is calculated to determine security capping, with excess amounts redistributed across the portfolio. The index is reweighted quarterly in January, April, July, and October, with annual reconstitution every July.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Nov 1, 2026, 06:51 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$25.95+$0.59 (+2.35%)
Amplify Weight Loss Drug & Treatment ETF’s quoted price sits in the upper half of its reported 52-week range, 7.12% below the high.
$21.31+$0.30 (+1.42%)
iREIT - MarketVector Quality REIT Index ETF’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$11.93+$0.38 (+3.26%)
Polen Capital Emerging Markets ex China Growth ETF’s quoted price sits in the upper half of its reported 52-week range, 7.82% below the high.
$25.77-$0.20 (-0.78%)
City Different Investments Global Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 5.3% below the high.
$30.61+$0.21 (+0.67%)
Westwood LBRTY Global Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 2.27% below the high.
$36.54+$0.12 (+0.34%)
AdvisorShares Hotel ETF’s quoted price sits in the upper half of its reported 52-week range, 4.62% below the high.
$19.74$0.00 (0.0%)
Columbia Research Enhanced Real Estate ETF’s quoted price sits in the lower half of its reported 52-week range, 15.96% below the high.
$27.20+$0.18 (+0.67%)
AdvisorShares Restaurant ETF’s quoted price sits in the lower half of its reported 52-week range, 13.97% below the high.